Management of Patients With Hepatitis C in a Community Population: Diagnosis, Discussions, and Decisions to Treat
Open Access
- 1 March 2004
- journal article
- Published by Annals of Family Medicine in Annals of Family Medicine
- Vol. 2 (2) , 116-124
- https://doi.org/10.1370/afm.62
Abstract
BACKGROUND Chronic hepatitis C, a treatable condition caused by the hepatitis C virus (HCV), can be found in almost all primary care and community practices. The rate of hepatitis C treatment is low, however. This study explores the frequency of hepatitis C treatment, documented discussions of treatment consideration, and the reasons treatment may not be offered in a community population.Keywords
This publication has 28 references indexed in Scilit:
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- Impact of Interferon Alfa–2B and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis CHepatology, 2000
- The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United StatesHepatology, 2000
- Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?Hepatology, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †Hepatology, 1998
- How Valid Are Medical Records and Patient Questionnaires for Physician Profiling and Health Services Research?Medical Care, 1998
- Phylogenetic Analysis of Hepatitis C Virus Isolates and Their Correlation to Viremia, Liver Function Tests, and HistologHepatology, 1996
- Clinical Toxicity of the InterferonsDrug Safety, 1994
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989